Search Results for “diagnostic” – Page 59 – media

FDA to Omit 501(k) Premarket Approval for Genetic Risk Tests

Today the FDA will officially exempt individual genetic risk tests from 501(k) premarket approval with the condition that the company offering the test should have a one-time premarket review of its testing apparatus and at least one test.
- Source: MobiHealthNews
- 715
- June 5, 2018
FDA genetic risk Market Views
NIPT to Detect Chromosomal Disorders in Unborn Babies

A study conducted in ten hospitals found that NIPT (Non-Invasive Prenatal Screening Test), was safer, more accurate and more effective in detecting chromosomal abnormalities in unborns, compared to conventional marker tests and ultrasound studies.
- Source: Ddu
- 564
- June 5, 2018
Down's syndrome NIPT pregnancy Researches
FDA Seeking Digital Health to Combat Opioid Abuse

In November, FDA’s device center will select which app is welcomed into the program, and the selected will have amplified interactions with FDA during the progress of their products. FDA will grant the advanced device nomination to products that meet the permitted criteria without requiring a separate application.
- Source: Ddu
- 788
- June 1, 2018
digital health mHealth New Approvals opioid
Delhi Minister States Essential Medicines Will Be Sold At MRP

Determined to cap the profits of private hospitals in Delhi and the NCR region, Delhi health minister Satyendra Jain has announced an array of new rules. He clearly stated that hospitals will be mandated to sell essential medicines at MRP and can no longer charge a markup.
- Source: Ddu
- 794
- May 29, 2018
India Market Views pharmaceutical drugs
Drinking Too Much Water Could Harm You

It is always advised to drink water. But recent studies have shown that there may be a limit as to how much. Overconsumption of water causes a decrease in sodium levels and fluid accumulates excessively in the brain, which leads to its swelling. This life-threatening condition, termed as Hyponatremia, is more commonly prevalent among the elderly.
- Source: Ddu
- 405
- May 29, 2018
health tips Researches
Indian Medical Devices Market – An Overview

The IVD sector in the country is chiefly characterized by 70 percent laboratories offering pathology services and 30 percent entities doling out radiology and imaging services. Though domestic players are flexing their muscles and are gearing to provide new-age diagnostic services with path-breaking innovations and strategic investments, multinational companies continue to hold sway over 60% of the domestic IVD market which is expected to grow by leaps and bounds in coming times.
- Source: Ddu
- 1,074
- May 28, 2018
India Market Views medical device products
Rise in China’s Global Pharma Market up to $175 billion by 2022 – Market Prediction

Though the US stands first in the race in terms of sales and growth, it is highly believed that China would reach the peak in the pharma market by 2022. At present, since there has been a decrease in public health funding, there has been a slight fall in pharmerging countries like Brazil, Russia, India and China (BRIC). But it is believed that the condition of these pharmerging countries will improve in the next five years [1].
- Source: Ddu
- 822
- May 24, 2018
China Market Views pharmaceutical drugs
Breast Cancer Diagnosis Using a Pill

A research team at the University of Michigan were developing a pill which shows the presence of tumors when exposed to infrared light, and their concept worked well in mice.
- Source: Ddu
- 802
- May 21, 2018
breast cancer cancer Researches
Odour Orders Malarial Transmission

A simple key strategy discovered by the research team at the London School of Tropical Medicine, will turn out to be a major breakthrough in the field of Malarial prevention. Malaria-infected children were more prone to malarial mosquitoes by producing distinctive skin smells, compared to uninfected children.
- Source: Ddu
- 510
- May 17, 2018
malaria Researches
FDA Approves Qiagen’s PartoSure for Preterm Labor

On April 20, 2018, Qiagen announced the FDA approval of the novel test named PartoSureTM, used for assessing the risk of spontaneous preterm birth in patients with symptoms of preterm labor.
- Source: Ddu
- 637
- May 17, 2018
medical device New Approvals preterm labor

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.